Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis

NCT01999192 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

321

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tregalizumab
DRUG: Placebo

Sponsor

Biotest

Collaborators

[object Object]